{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:43:04Z","timestamp":1765546984199,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ygyno.2022.10.018","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T01:02:14Z","timestamp":1668646934000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery"],"prefix":"10.1016","volume":"168","author":[{"given":"Minh Tung","family":"Phung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"DeFazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Fereday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.L.","family":"Bowtell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen L.","family":"Goode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc T.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesmary","family":"Modugno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Brenton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.P.","family":"Pharoah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joellen M.","family":"Schildkraut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Meza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhramar","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn","family":"Grout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Chase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"McKinnon Deurloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian E.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Ramus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste Leigh","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2022.10.018_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2018.08.016","article-title":"Histotype classification of ovarian carcinoma: a comparison of approaches","volume":"151","author":"Peres","year":"2018","journal-title":"Gynecol. Oncol."},{"year":"2022","series-title":"Cancer Facts & Figures 2022ed","author":"American Cancer Society","key":"10.1016\/j.ygyno.2022.10.018_bb0015"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian Cancer survival by Histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0025","first-page":"CD007565","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"2011","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2017.10.011","article-title":"Predictive modeling for determination of microscopic residual disease at primary cytoreduction: an NRG oncology\/gynecologic oncology group 182 study","volume":"148","author":"Horowitz","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0040","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.7150\/jca.15724","article-title":"Preoperative lymphocyte-monocyte ratio is a predictor of suboptimal cytoreduction in stage III-IV epithelial ovarian cancer","volume":"7","author":"Eo","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","article-title":"A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer","volume":"145","author":"Suidan","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0050","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ygyno.2020.06.481","article-title":"Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival","volume":"158","author":"Brieger","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0055","first-page":"509","article-title":"Does endometriosis hinder successful ovarian debulking surgery?","volume":"19","author":"Sananpanichkul","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0060","first-page":"2447","article-title":"Increased ERCC1 protein expression is associated with suboptimal debulking in advanced epithelial ovarian cancer","volume":"30","author":"Lin","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187245","article-title":"A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer","volume":"12","author":"Chesnais","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0070","first-page":"1319","article-title":"Model for prediction of optimal debulking of epithelial ovarian cancer","volume":"19","author":"Arab","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.04.013","article-title":"Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer","volume":"138","author":"Janco","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1037\/1082-989X.6.4.330","article-title":"A comparison of inclusive and restrictive strategies in modern missing data procedures","volume":"6","author":"Collins","year":"2001","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/igc.0000000000001132","article-title":"National trends in extended procedures for ovarian cancer debulking surgery","volume":"28","author":"Jones","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17517","article-title":"Trends in primary treatment and median survival among women with advanced-stage epithelial ovarian cancer in the US from 2004 to 2016","volume":"3","author":"Knisely","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2020.02.020","article-title":"Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III\/IV ovarian, tubal and peritoneal cancers in phase III randomised trial","volume":"130","author":"Onda","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0110","series-title":"Survival analyses from a randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer with high tumor load (SCORPION trial)","first-page":"5516","volume":"vol. 36","author":"Fagotti","year":"2018"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.02.005","article-title":"Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development","volume":"158","author":"Jeon","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0120","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1349-7006.2008.00853.x","article-title":"Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy","volume":"99","author":"Ono","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0125","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jbspin.2012.11.008","article-title":"Estrogens, osteoarthritis and inflammation","volume":"80","author":"Mart\u00edn-Mill\u00e1n","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0135","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clnu.2016.08.013","article-title":"Smoking status is inversely associated with overall diet quality: findings from the ORISCAV-LUX study","volume":"36","author":"Alkerwi","year":"2017","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ygyno.2012.05.001","article-title":"Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma","volume":"126","author":"Hyman","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0150","first-page":"4133","article-title":"Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancer","volume":"26","author":"Beesley","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0155","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1677\/ERC-08-0104","article-title":"Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk","volume":"15","author":"Goodman","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/EDE.0b013e3182456ad3","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer","volume":"23","author":"Lo-Ciganic","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.ygyno.2022.10.018_bb0165","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-09-2553","article-title":"Inherited determinants of ovarian cancer survival","volume":"16","author":"Goode","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0170","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/0008-5472.CAN-07-5165","article-title":"Genetic variation in the one-carbon transfer pathway and ovarian cancer risk","volume":"68","author":"Kelemen","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2022.10.018_bb0175","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1158\/0008-5472.CAN-04-3885","article-title":"Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk","volume":"65","author":"Terry","year":"2005","journal-title":"Cancer Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822018959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822018959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:03:05Z","timestamp":1758772985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822018959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":35,"alternative-id":["S0090825822018959"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.10.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}